{"id":282,"date":"2012-03-05T20:16:44","date_gmt":"2012-03-05T20:16:44","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=282"},"modified":"2026-02-25T20:40:58","modified_gmt":"2026-02-25T20:40:58","slug":"correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/","title":{"rendered":"Correlation of tumor BRAF mutations and MLH1 methylation with germline MMR gene mutation status: a literature review assessing utility of tumor features for MMR variant classification (Contributed by Dr Amanda B Spurdle)"},"content":{"rendered":"

Lynch Syndrome is a heritable disorder characterized by increased risk of colorectal, endometrial and other cancers. It is caused by mutations in the DNA mismatch repair (MMR) genes. We conducted a literature review of published studies that investigated MMR gene mutation status and two tumor characteristics commonly used to exclude individuals with colorectal cancer from MMR gene mutation testing: BRAF V600E mutation status and MLH1 promoter methylation status. We showed that BRAF mutation status and MLH1 methylation are strong negative predictors of MMR mutation status, but are not definitive. These tumor characteristics should be used in conjunction with other data points in statistical models that predict likely mutation status. (http:\/\/jmg.bmj.com\/content\/49\/3\/151<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

Lynch Syndrome is a heritable disorder characterized by increased risk of colorectal, endometrial and other cancers. It is caused by mutations in the DNA mismatch repair (MMR) genes. We conducted a literature review of published studies that investigated MMR gene mutation status and two tumor characteristics commonly used to exclude individuals with colorectal cancer from […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-282","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nCorrelation of tumor BRAF mutations and MLH1 methylation with germline MMR gene mutation status: a literature review assessing utility of tumor features for MMR variant classification (Contributed by Dr Amanda B Spurdle) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Correlation of tumor BRAF mutations and MLH1 methylation with germline MMR gene mutation status: a literature review assessing utility of tumor features for MMR variant classification (Contributed by Dr Amanda B Spurdle) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Lynch Syndrome is a heritable disorder characterized by increased risk of colorectal, endometrial and other cancers. It is caused by mutations in the DNA mismatch repair (MMR) genes. We conducted a literature review of published studies that investigated MMR gene mutation status and two tumor characteristics commonly used to exclude individuals with colorectal cancer from [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2012-03-05T20:16:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-25T20:40:58+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Correlation of tumor BRAF mutations and MLH1 methylation with germline MMR gene mutation status: a literature review assessing utility of tumor features for MMR variant classification (Contributed by Dr Amanda B Spurdle)\",\"datePublished\":\"2012-03-05T20:16:44+00:00\",\"dateModified\":\"2026-02-25T20:40:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\\\/\"},\"wordCount\":147,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\\\/\",\"name\":\"Correlation of tumor BRAF mutations and MLH1 methylation with germline MMR gene mutation status: a literature review assessing utility of tumor features for MMR variant classification (Contributed by Dr Amanda B Spurdle) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2012-03-05T20:16:44+00:00\",\"dateModified\":\"2026-02-25T20:40:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Correlation of tumor BRAF mutations and MLH1 methylation with germline MMR gene mutation status: a literature review assessing utility of tumor features for MMR variant classification (Contributed by Dr Amanda B Spurdle)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Correlation of tumor BRAF mutations and MLH1 methylation with germline MMR gene mutation status: a literature review assessing utility of tumor features for MMR variant classification (Contributed by Dr Amanda B Spurdle) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/","og_locale":"en_US","og_type":"article","og_title":"Correlation of tumor BRAF mutations and MLH1 methylation with germline MMR gene mutation status: a literature review assessing utility of tumor features for MMR variant classification (Contributed by Dr Amanda B Spurdle) - JMG Contact blog","og_description":"Lynch Syndrome is a heritable disorder characterized by increased risk of colorectal, endometrial and other cancers. It is caused by mutations in the DNA mismatch repair (MMR) genes. We conducted a literature review of published studies that investigated MMR gene mutation status and two tumor characteristics commonly used to exclude individuals with colorectal cancer from [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/","og_site_name":"JMG Contact blog","article_published_time":"2012-03-05T20:16:44+00:00","article_modified_time":"2026-02-25T20:40:58+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Correlation of tumor BRAF mutations and MLH1 methylation with germline MMR gene mutation status: a literature review assessing utility of tumor features for MMR variant classification (Contributed by Dr Amanda B Spurdle)","datePublished":"2012-03-05T20:16:44+00:00","dateModified":"2026-02-25T20:40:58+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/"},"wordCount":147,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/","url":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/","name":"Correlation of tumor BRAF mutations and MLH1 methylation with germline MMR gene mutation status: a literature review assessing utility of tumor features for MMR variant classification (Contributed by Dr Amanda B Spurdle) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2012-03-05T20:16:44+00:00","dateModified":"2026-02-25T20:40:58+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/correlation-of-tumor-braf-mutations-and-mlh1-methylation-with-germline-mmr-gene-mutation-status-a-literature-review-assessing-utility-of-tumor-features-for-mmr-variant-classification\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Correlation of tumor BRAF mutations and MLH1 methylation with germline MMR gene mutation status: a literature review assessing utility of tumor features for MMR variant classification (Contributed by Dr Amanda B Spurdle)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=282"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/282\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}